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4-Diphosphocytidyl-2C-methyl-d-erythritol kinase (IspE) catalyses the
ATP-dependent conversion of 4-diphosphocytidyl-2C-methyl-d-erythritol
(CDPME) to 4-diphosphocytidyl-2C-methyl-d-erythritol 2-phosphate with
the release of ADP. This reaction occurs in the non-mevalonate pathway
of isoprenoid precursor biosynthesis and because it is essential in important
microbial pathogens and absent from mammals it represents a potential
target for anti-infective drugs. We set out to characterize the biochemical
properties, determinants of molecular recognition and reactivity of IspE
and report the cloning and puriﬁcation of recombinant Aquifex aeolicus
IspE (AaIspE), kinetic data, metal ion, temperature and pH dependence,
crystallization and structure determination of the enzyme in complex with
CDP, CDPME and ADP. In addition, 4-ﬂuoro-3,5-dihydroxy-4-methyl-
pent-1-enylphosphonic acid (compound 1) was designed to mimic a frag-
ment of the substrate, a synthetic route to 1 was elucidated and the
complex structure determined. Surprisingly, this ligand occupies the bind-
ing site for the ATP a-phosphate not the binding site for the methyl-d-ery-
thritol moiety of CDPME. Gel ﬁltration and analytical ultracentrifugation
indicate that AaIspE is a monomer in solution. The enzyme displays
the characteristic a⁄b galacto-homoserine-mevalonate-phosphomevalonate
kinase fold, with the catalytic centre positioned in a deep cleft between the
ATP- and CDPME-binding domains. Comparisons indicate a high degree
of sequence conservation on the IspE active site across bacterial species,
similarities in structure, speciﬁcity of substrate recognition and mechanism.
The biochemical characterization, attainment of well-ordered and reproduc-
ible crystals and the models resulting from the analyses provide reagents
and templates to support the structure-based design of broad-spectrum
antimicrobial agents.
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products and include primary and secondary metabo-
lites such as sterols, dolichols and triterpenes, the
prenyl groups of chlorophyll and modiﬁed proteins.
Isoprenoids contribute to important biological func-
tions including respiration, photosynthesis, hormone-
based signalling, apoptosis, meiosis and protein
degradation, and in addition, provide important
structural components of cell membranes [1–3].
Two biosynthetic pathways to isopentenyl diphos-
phate and dimethylallyl disphosphate, the basic ﬁve-
carbon precursors for all isoprenoids, have evolved.
The mevalonate pathway, named after one of its
constituent metabolites, is found in archaebacteria,
some eubacteria, yeast, the cytosolic compartment of
plants and animals. In chloroplasts, algae, cyanobacte-
ria, most eubacteria and the apicomplexa, the biosyn-
thesis of isopentenyl diphosphate and dimethylallyl
disphosphate is via the non-mevalonate pathway [4–7].
Species that utilize and are dependent on the non-me-
valonate pathway include the causal agents for impor-
tant human diseases such as leprosy, tuberculosis and
malaria. The enzymes of this pathway are absent from
humans and have attracted interest as potential targets
for antimicrobial drug screening [8], structure-based
drug discovery and design [4].
Our interest centres on 4-diphosphocytidyl-2C-
methyl-d-erythritol kinase (IspE, EC 2.7.1.148), which
catalyses the transfer of the ATP c-phosphate to
4-diphosphocytidyl-2C-methyl-d-erythritol (CDPME)
forming 4-diphosphocytidyl-2C-methyl-d-erythritol
2-phosphate (CDPME2P) and ADP (Fig. 1) [9,10].
IspE is a GHMP kinase, named after the four found-
ing members of this protein superfamily namely galac-
to, homoserine, mevalonate and phosphomevalonate
kinases [11,12]. The crystal structure of the Escherichi-
a coli orthologue (EcIspE) in complex with a stable
ATP analogue, adenosine 5¢-(b,c-imino)triphosphate
(AMP-PNP) and CDPME, as well as the apo-structure
of the Thermus thermophilus enzyme (TtIspE) have
been reported [13,14].
Research with IspE from several organisms has been
hampered because the recombinant proteins have low
solubility. Here, we show that IspE from the thermo-
philic bacterium Aquifex aeolicus (AaIspE) provides an
efﬁcient expression system of a stable and soluble
recombinant enzyme. This has allowed, for the ﬁrst
time, detailed biochemical and kinetic characterization
of IspE, determination of the metal ion and tempera-
ture dependence and optimum pH. The enzyme gives
well-ordered crystals and we applied multiple-wave-
length anomalous dispersion phasing methods to a
selenomethionine (SeMet) derivative to solve the
structure. Complexes with cytidine, CDP, CDPME,
ADP and the newly synthesized ligand, 4-ﬂuoro-3,5-
dihydroxy-4-methylpent-1-enylphosphonic acid (1), are
reported.
Results and Discussion
Biochemical and kinetic characterization
The putative ispE gene from A. aeolicus was placed
under the control of the T7 promoter and lac operator
in the hyperexpression plasmid pET-15b, and heat
transformed into E. coli BL21 (DE3). The gene was
preceded by a His6 tag to enable puriﬁcation of the
recombinant protein via metal-chelating afﬁnity chro-
matography. The polyhistidine tag was removed by
thrombin-mediated proteolysis, followed by puriﬁca-
tion with anion-exchange chromatography. The pro-
tein was puriﬁed to homogeneity with a yield of
Fig. 1. The reaction catalysed by IspE together with the structure
of 1 to highlight similarity with part of the substrate.
Aquifex aeolicus IspE T. Sgraja et al.
2780 FEBS Journal 275 (2008) 2779–2794 ª 2008 The Authors Journal compilation ª 2008 FEBS 15 mg protein per litre of cell culture. The protein
had an apparent mass of 30 kDa, as judged by gel-
ﬁltration chromatography, which is in a good agree-
ment with a sedimentation velocity experiment affording
a calculated mass of 29.8 kDa (data not shown).
The catalytic activity of the recombinant IspE pro-
tein was measured by
13C NMR spectroscopy and
photometry. The
13C NMR measurement was per-
formed using the multiply
13C-labelled substrate
[1,3,4-
13C3]CDPME to enhance the sensitivity and
selectivity of
13C observation.
13C NMR signals
detected in a typical NMR assay are shown in Fig. 2.
The chemical shifts as well as the
13C
13C-coupling con-
stants were in excellent agreement with the published
data on CDPME [15] and CDPME2P [9]. Optimal
activity was identiﬁed at pH 8.5 and  60  C (Fig. 3).
AaIspE was catalytically active in the presence of vari-
ous metal ions (Table 1), and a highest rate of
1.5 lmolÆmin
)1Æmg
)1 was achieved in the presence of
2m m Mg
2+ or Mn
2+ (Fig. 4). The photometric assay
was performed according to a published procedure [8]
using auxiliary enzymes to observe the decrease in
NADH absorption at 340 nm. The KM values for
CDPME and ATP were determined as 121 and
222 lm, respectively (Table 2, Fig. 5). The data are
similar to the kinetic properties reported for IspE from
E. coli [16] and tomato [17], respectively.
Overall structure of AaIspE
Ordered and reproducible crystals of AaIspE
were obtained and multiple-wavelength anomalous
Fig. 2.
13C NMR spectra of an enzymatic assay with AaIspE. (A)
Signals of [1,3,4-
13C3]CDPME before incubation; (B) 65% conver-
sion from [1,3,4-
13C3] CDPME into [1,3,4-
13C3] CDPME2P. The
13C NMR signals of the substrate and the product agree published
data [8].
Fig. 3. pH and temperature dependence of AaIspE. (A) Relative
activity versus pH. The measurements were performed using the
photometric assay as described in Experimental procedures in a
buffer containing 50 mM citrate, 50 mM Hepes, 50 mM Tris⁄HCl
and 50 mM boric acid in a total volume of 200 lL. pH was adjusted
to values of 5-10 with hydrochloric acid and sodium hydroxide,
respectively. (B) Speciﬁc activity at different temperatures, inset:
Arrhenius plot. The measurements were performed using the NMR
assay as described in Experimental procedures.
Table 1. Metal ion dependence of AaIspE. Measurements were
performed using the NMR assay as described in Experimental
procedures with 5 mM divalent metal ions.
Metal Relative activity (%)
None 0
Mg
2+ 100
Mn
2+ 94
Co
2+ 52
Cu
2+ 40
Fe
2+ 16
Zn
2+ 14
Ni
2+ 11
Ca
2+ 8
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phases. Subsequently, three medium-resolution com-
plex crystal structures were determined (Tables 3 and
4). The crystals are isomorphous with two molecules,
total molecular mass  60 kDa, in the asymmetric
unit. The molecules, A and B, are related by a non-
crystallographic twofold axis (data not shown). The
surface area between the two molecules is  540 A ˚ per
molecule,  4% of the total surface area of the pro-
tein. This low value is consistent with gel-ﬁltration and
ultracentrifugation experiments that indicate AaIspE is
a monomer in solution (data not shown).
There are two molecules per asymmetric unit and
therefore the three crystal structures provide six crys-
tallographically independent molecules. These mole-
cules are highly similar. Pair-wise least-squares
superpositions give a range of r.m.s.d. of 0.17–0.46 A ˚
for all Ca positions with a mean of 0.33 A ˚ . Only
Fig. 4. Mg
2+ and Mn
2+ dependence. The optimum concentration
of both metals is 2 mM.
Table 2. Kinetic parameters of AaIspE.
Kinetic parameters Values
Vmax at 37  C 1.5 lmolÆmin
)1Æmg
)1
Km of 4-diphosphocytidyl-2-C-
methyl-D-erythritol
121 lM
Km of ATP 222 lM
Metal of choice Mn
2+,M g
2+
pH optimum 8.5
Temperature maximum 60  C
Activation energy 64.2 kJÆmol
)1
Fig. 5. Substrate dependence of AaIspE. (A) Michaelis–Menten
kinetics showing initial rate versus ATP concentration. (B) Michael-
is–Menten kinetics showing initial rate versus CDPME concentra-
tion; insets, Lineweaver–Burk; dotted lines show 95% conﬁdence.
Measurements were performed using the photometric assay as
described in Experimental procedures. The concentration of ATP
and CDPME were varied from 10 to 1300 lM, respectively.
Table 3. Multiple-wavelength anomalous dispersion data statistics. Numbers in parentheses are for the highest resolution shell, a bin of
0.15 A ˚.
k1 k2 k3
Observed⁄unique reﬂections 219 842⁄24 238 220 860⁄24 266 222 261⁄24 265
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Multiplicity⁄Rmerge (%) 9.1 (8.6)⁄10.8 (44.2) 9.1 (8.6)⁄10.5 (42.9) 9.2 (8.9)⁄10.5 (43.9)
<I⁄r (I)> 16.9 (4.2) 17.9 (4.4) 17.6 (4.3)
Aquifex aeolicus IspE T. Sgraja et al.
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ﬂexible side chains on a6 and the loop region follow-
ing a4. The binding mode of the ligands differs only
slightly within the asymmetric units and will be
described in detail when applicable.
AaIspE displays the typical GHMP kinase fold that
comprises two domains (Fig. 6) [13]. The N-terminal
domain (residues 1–155) consists of an elongated six-
stranded b sheet (b1–b6). In addition, the concave side
of the b sheet is ﬂanked by three a helices (a1–a3) and
two 310 helices (h1 and h2). The C-terminal domain
comprises an antiparallel four-stranded b sheet (b7–
b10), bordering b1 and b2 of the N-terminal domain,
four a helices (a4–a7) and two 310 helices (h3 and h4).
GHMP kinases have three conserved motifs that
help create the catalytic centre [12,18,19]. In AaIspE
(Fig. 7) the residues of motif 1 (Lys9 to Leu14) are on
b1 of the N-terminal domain and interact with
CDPME, residues of motif 2 (Ile87 to Ser98) and
motif 3 (Val235 to Val242), interact with the triphos-
phate component of ATP (see later). Motif 3 com-
prises the b8–b9 loop, which does not interact with the
ligands but stabilizes the conformation of motifs 1 and
2 via hydrogen-bonding contacts. For example, Ser236
OG and Gly237 N form contacts with Asn11 OD1 of
motif 1, Ser236 OG interacts with Gly92 O of motif 2,
whereas Ser240 N and Thr241 OG1 donate hydrogen
bonds to Gly90 O and Ala91 O respectively (not
shown). Motif 2 is part of the b4–a2 loop, commonly
described as the phosphate binding or P-loop. The
main-chain amides of this glycine-rich motif and the
a3 dipole surround the negatively charged phosphates
of the nucleotide. The details of interactions formed
between the enzyme motifs together with additional
parts of the active site and the ligands are presented
after comparison with structures of IspE orthologues.
Comparison of IspE structures
AaIspE shares the highest sequence identity with
TtIspE (32%) and slightly less with EcIspE (30%).
The alignment of EcIspE with AaIspE in shown in
Fig. 7. The DALI server [20] identiﬁed EcIspE
(Z-score: 29.1) and TtIspE (Z-score: 27.7) as most sim-
ilar to AaIspE. (The Z-score is a measure of the statis-
tical signiﬁcance of the best subunit–subunit alignment
and was determined by DALI. Typically, dissimilar
proteins will have a Z-score < 2.0.) Ca superpositions
of EcIspE and TtIspE with AaIspE give r.m.s.d values
of 1.6 and 1.8 A ˚ , respectively, which mainly corre-
spond to differences in the C-terminal domain distant
from the active site. An overlay of AaIspE and EcIspE
Table 4. Crystallographic statistics. Numbers in parentheses represent the highest resolution bin of width  0.06 A ˚.
Complex I Complex II Complex III
Space group P213 P213 P213
Unit cell length
a=b=c(A ˚)
137.1 136.9 137.2
Resolution range (A ˚) 40–2.1 40.0–2.25 40.0–2.30
No. observed⁄unique
reﬂections
262 443⁄49 871 304 071⁄40 884 285 651⁄38 442
Wilson B (A ˚ 2) 32.8 37.8 39.4
Completeness (%) 99.4 (95.7) 100.0 (100.0) 100.0 (100.0)
Multiplicity⁄Rmerge (%) 5.3 (4.1)⁄6.4 (45.2) 7.4 (7.6)⁄13.7 (49.1) 7.4 (7.4)⁄11.6 (50.4)
<I⁄r(I)> 17.1 (3.1) 12.1 (2.9) 14.2 (3.3)
Rwork⁄Rfree (%) 20.8 (28.3)⁄25.2 (33.8) 20.2 (24.8)⁄22.9 (29.6) 19.7 (24.3)⁄24.5 (32.4)
r.m.s.d. from ideal bond
lengths (A ˚)⁄angles ( )
0.008⁄1.186 0.008⁄1.168 0.008⁄1.096
Average B values (A ˚ 2)
Overall⁄main chain⁄
side chain⁄waters⁄
ligands
30.9⁄30.4⁄31.4⁄38.8
(2 CDP 30.7; 2 ADP 43.8;
4S O 4
2) 53.9; 2 Cl
) 23.1)
30.9⁄30.3⁄31.4⁄36.0
(2 CDPME 30.9; 2 ADP 39.7; 3
SO4
2) 59.4; 3 Cl
) 28.0)
30.0⁄29.5⁄30.5⁄37.9
(2 CTN 41.1; 1 ligand 43.2;
8S O 4
2) 54.9; 2 Cl
) 19.5)
Ramachandran plot analysis
Most favourable
regions (%)
94.3 94.9 94.0
Additional allowed
regions (%)
5.3 4.6 5.5
DPI
a (A ˚) 0.20 0.23 0.25
a Diffraction-Component Precision Index [43].
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secondary structure are well conserved. With respect to
AaIspE, a5 and a7 are situated at different positions
in EcIspE (Fig. 8) and TtIspE structures, and an addi-
tional helix following b10 is inserted in EcIspE. The
two structures are further decorated with a 310 helix
following a7o ra4 respectively (not shown). The struc-
tural comparison and alignment of AaIspE with
EcIspE reveals a high degree of conservation within
the active site (Fig. 8). Alignment of the Mycobacte-
rium tuberculosis IspE (MtbIspE) sequence with those
of AaIspE and EcIspE indicates sequence identities of
around 25% (Fig. 7). This comparison is detailed
later.
The substrate-binding site
Three crystal structures of AaIspE in complex with
ligands were determined. Although data for complex I
were measured from AaIspE co-crystallized with the
relatively stable ATP analogue AMP-PNP only ADP
could be modeled. Similarly, CDPME2P was present
in the crystallization conditions for the sample used to
derive complex II, but only CDPME was observed.
The lack of electron density for the terminal phosphate
groups of CDPME2P and AMP-PNP is either a result
of disorder and⁄or hydrolysis. In complex III, cytidine,
ADP and 1 are present. The structures and interac-
tions formed between AaIspE and the ligands are simi-
lar in each complex and we concentrate on the details
of complex II to indicate how substrate and ADP bind
and then describe the speciﬁcs of interactions with 1.
The substrate CDPME binds into a deep cavity
between the N- and C-terminal domains, surrounded
by residues on b1, a4, the N-terminal end of b2 and
Fig. 7. Primary and secondary structure of AaIspE and sequence alignment of A. aeolicus (Aa), E. coli (Ec) and M. tuberculosis (Mtb) ortho-
logues. Residues conserved in all three sequences are boxed in black, those conserved in two of the three sequences are boxed in red.
Three GHMP kinase superfamily conserved motifs are marked. The secondary structure of AaIspE is shown with helices as red cylinders
and strands as cyan arrows. Residues marked with a star interact with substrate (yellow indicates a direct interaction, blue interactions
bridged by water molecules). Thr171 is marked with a red star to indicate that it interacts with both CDPME and ADP. Residues marked
with a dot interact with ADP (green indicates a direct interaction, blue water mediated interactions).
Fig. 6. Ribbon diagram of AaIspE. a and 310 helices are red and
b strands are cyan. Secondary structure elements have been
labelled, N- and C-termini are marked. ADP is gold, the substrate
CDPME green.
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hydrogen bonds to the pyrimidine (Fig. 9A). The imid-
azole ND1 and main-chain amide donate hydrogen
bonds to the nucleotide O2 and N3 respectively,
whereas the carbonyl accepts a hydrogen bond from
N4. N4 further interacts with the main-chain carbonyl
Fig. 8. Stereo-view Ca overlay of AaIspE
and EcIspE. AaIspE is shown in red with
EcIspE in black. Also depicted are the ADP
(gold) and CDPME (green) from the AaIspE
complex I. The positions of a5 and a7 are
marked.
A
B
Fig. 9. IspE ligand interactions in complex I.
In both sections of this ﬁgure atoms are col-
oured blue N, red O and orange P. The C
atoms of protein are beige, of CDPME
green and ADP yellow. Residues that inter-
act with the ligands are labelled, water mol-
ecules have been omitted for the purpose
of clarity and some of the potential hydro-
gen bonds are shown as black dashed lines.
(A) Stereo-view of the CDPME-binding site.
(B) Stereo-view of the ADP-binding site.
T. Sgraja et al. Aquifex aeolicus IspE
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hydrophobic contacts with the side chains of Tyr24
and Tyr175, the latter forming p–p stacking interac-
tions with the cytidine. Tyr175 is replaced in EcIspE
by a phenylalanine, a conservative substitution and we
note a degree of ﬂexibility for this side chain because it
adopts slightly different conformations in the three
AaIspE complex structures and with elevated thermal
parameters compared with the more buried Tyr24. A
large aromatic residue at this position in the active site
may act as a gatekeeper during substrate binding and
product release.
The ribose is solvent accessible and water-mediated
contacts link O2¢, Ser176 OG and the main-chain car-
bonyl of Gly172. The a-phosphate accepts a hydrogen
bond donated from the main-chain amide of Ala129,
and the b-phosphate interacts with Ser128 OG, the
amide of Asp130 and also, via a solvent-mediated
bridge, with Ser97 OG (not shown). The erythritol
moiety of CDPME protrudes into a cavity in which
catalytic residues Lys9 and Asp130 are placed. An
extensive network of hydrogen-bonding interactions
positions key residues and functional groups on sub-
strate to support catalysis. Lys9 NZ is held in place by
a hydrogen bond with Asn11 OD1. Three additional
hydrogen bonds serve to position Asn11. OD1 also
accepts a hydrogen bond donated from the main-chain
amide of Gly237 and ND2 donates hydrogen bonds to
Thr29 OG1 and to the substrate O1M hydroxyl. O1M
forms a bidentate interaction with Asp130 OD1 and
OD2. The O3M hydroxyl interacts with Tyr175 OH
and a well-ordered water molecule that, in turn, forms
hydrogen bonds with the main-chain carbonyl of
Lys145 and Asp130 OD1 (data not shown). The
methyl substituent on C2 is directed towards a hydro-
phobic pocket formed by the side chains of Tyr175
and Leu208.
The O2M group, where phosphate addition occurs,
participates in hydrogen bonds with Lys9 NZ, Asp130
OD2 and a water molecule (not shown) that in turn
associates with the main-chain amide and OG of
Ser238, and b-phosphate of ADP. The placement and
interactions formed by O2M are consistent with a
mechanism that involves polarization of the hydroxyl
group and Asp130 acting as a general base in proton
abstraction to generate a nucleophile. This can then
attack and acquire the reactive c-phosphate of ATP
with Lys9 NZ, and Ser238 amide and OG groups
placed to stabilize the transition state. An overlay of
the EcIspE AMPPNP complex [13] with AaIspE places
the c-phosphate group towards the catalytic residues
Lys9 and Asp130 in a position consistent with the
proposed mechanism (not shown).
In complex I, CDP displays a single conformation in
molecule A and three in molecule B (not shown). Such
conformational freedom, distinct from the ordered
substrate, may reﬂect loss of the methylerythritol com-
ponent and the numerous stabilizing interactions that
it forms deep within the enzyme active site. The
cytosine moieties of the four CDP molecules interact
with Tyr24, His25, Lys145 and Tyr175, as described
previously, with differences (not shown) conﬁned to
the orientation and binding modes of the solvent-
exposed ribose and phosphate groups. In molecules A
and B, the ribose O2¢ interacts with the carbonyl of
Gly23 via a water molecule. In addition, in mole-
cule A, this group also interacts with the Gly172
carbonyl and Ser176 OG via water molecules; the
a-phosphate interacts with Ser138 OG via a water
molecule and the b-phosphate forms a direct hydrogen
bond with Tyr24 OH. One CDP conformer in mole-
cule B is similar to that observed in molecule A. In the
second conformer in molecule B the a-phosphate occu-
pies a similar position but the b-phosphate group is
directed out of the active site to interact with both
Tyr24 OH and the carbonyl of Ile127. This latter inter-
action suggests that protonation of the phosphate has
occurred. In the third conformer the a-phosphate
interacts with the backbone amide of Gly172, the
b-phosphate group with the Ser169 carbonyl, Thr171
amide and OG1.
The ATP-binding site
ADP binds in a cavity formed by the N-terminal
domain adjacent to the CDPME-binding site (Figs 6
and 9B). The ADP is surrounded by residues in b2, at
the N-terminal end of a1 and a2 and in the b4–a2 and
b3–h1 loops. ATP generally binds to kinases with the
purine in an anti conformation with respect to the
ribose. There are, however, two exceptions in which
the energetically less favourable syn conformation is
observed, EcIspE [13] and the related homoserine
kinase [21]. In AaIspE the syn conformation is also
observed with the adenine moiety placed in a hydro-
phobic cleft surrounded by aliphatic side chains of
Ile53, Ile55, Leu61, Ile83 and Lys85 with contributions
from Pro89 and Gly96. The purine conformation is
stabilized by hydrogen-bonding contacts. Two aspara-
gines (Asn60 and Asn99), themselves positioned by a
network of hydrogen-bonding interactions, are placed
to accept hydrogen bonds donated by adenine N6.
Asn60 OD1 interacts with the amide of Val62, ND2
forms water-mediated contacts with Val49 and Ile55
carbonyl groups. Asn99 OD1 accepts hydrogen bonds
from adenine N6 and Lys85 NZ, ND2 interacts with
Aquifex aeolicus IspE T. Sgraja et al.
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with Lys85 NZ, which is held in place by interaction
with Asp38 and via a water molecule with the ADP
a-phosphate. The amide of Leu61 donates a hydrogen
bond to adenine N7. The ribose and phosphate groups
of the ADP are solvent accessible and the a–b-linking
oxygen forms a water-mediated contact with the Pro88
carbonyl and Leu93 amide. The b-phosphate accepts
hydrogen bonds donated by amides of Gly92 and
Gly94, and is linked to the Gly239 and Ser169 carbo-
nyls, Lys9, Asp130 and Ser238 side-chain groups via
water molecules. Another water-mediated interaction is
formed between Thr171 OD1 and the ADP b-phos-
phate. In AaIspE and EcIspE complex structures, the
adenine and ribose moieties bind in a similar position
with highly conserved hydrogen-bonding interactions.
The phosphate groups, however, adopt different con-
formations in the two structures, which may simply
reﬂect the difference between AMP-PNP present in the
EcIspE structure and ADP in AaIspE (not shown).
The amide of Gly97 binds to the ADP a-phosphate in
AaIspE, whereas the corresponding Gly107 of EcIspE
coordinates to the b-phosphate. Furthermore, the
Gly103 amide binds to the AMP-PNP c-phosphate in
EcIspE, whereas it is the b-phosphate that binds to the
amide of the corresponding Gly92 in AaIspE.
Based on comparisons of the apo-structure of
TtIspE with the Mg
2+-bound crystal structures of
homoserine kinase [21] and mevalonate kinase [22]
Wada et al. [14] suggested that a metal ion would bind
to Ser95 and Asp125 (corresponding to Ser97 and
Asp130 in AaIspE). To investigate metal-ion binding
in the catalytic site, AaIspE was co-crystallized in the
presence of 20 mm magnesium chloride or manganese
chloride together with ADP or AMP-PNP and several
crystal structures determined at medium resolution
(data not shown). However, despite the clear depen-
dence of activity on divalent cations, and in similar
fashion to EcIspE [13], we were unable to identify the
position of any ordered metal ions in the active site of
AaIspE.
Synthesis and binding of compound 1
The conjugated ﬂuoro-MEP derivative compound 1
was designed as a fragment mimic of the b-phosphate
and erythritol moiety of the substrate CDPME. The
compound was expected to be a competitive inhibitor
and to bind in a similar position to that observed for
that component of the substrate represented in com-
plex II. It was ﬁrst necessary to determine a synthetic
method for the molecule. Synthesis of 1 began with the
enantiomerically pure ﬂuorodiol 2, which was pro-
tected to afford the triol 3 (Scheme 1). Removal of the
para-methoxybenzyl (PMB) was achieved by use of
Yu’s Lewis acid catalyzed conditions to give 4. The
free primary alcohol was then oxidized under Swern
conditions and the resulting aldehyde 5 subjected to a
Horner–Wadsworth Emmons oleﬁnation to afford the
E-conjugated phosphonate ester 6 in quantitative yield
and as a single double bond isomer. Double bond
geometry was assigned by
1H NMR analysis (J =
17 Hz). The silyl protecting groups were removed
under standard triﬂuoroacetic acid (TFA) conditions
to give the free 1,3-diol 7 in good yield.
Having unmasked the diol functionality, it was then
necessary to free the vinyl phosphate. Treatment of 7
with bromotrimethylsilane (TMSBr) generated the
desired enantiomerically pure vinyl phosphate 1 in
reasonable yield (Scheme 2).
We were unable to detect any ligand binding or
enzyme inhibition of AaIspE by 1 (data not shown),
suggesting low afﬁnity for the enzyme. However, we
were able to determine the crystal structure of the
complex where the ligand was bound to one molecule
of the asymmetric unit following soaking of a crystal
TBSOTf
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85%
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PMBO
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F
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OTBS
HO
Swern
OTBS
F
OTBS OHC
EtO
PP
OEt
OO
OEt EtO
nBuLi
Quantitative
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Scheme 1. The outline for synthesis of the
protected phosphonate ester compound 6.
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the phosphonate occupying a similar position to that
observed for the ADP⁄ATP a-phosphate not the
b-phosphate of substrate (Fig. 10). The phosphate is
positioned by hydrogen bonding to the main-chain
amides Gly95 and Gly96, and water-mediated interac-
tions with the carbonyl of Pro88, the amide of Leu93
together with the amide and OG groups of Ser97. The
ligand C3 OH interacts with the amide groups of
Leu93 and Gly94, the ﬂuorine substituent at C4 with
Ser238 OG and, via a water molecule, also with the
carbonyl groups of Ser169 and Gly239, and Thr171
OD1. The C5 hydroxyl makes one hydrogen bond to a
water molecule and is 3.2 A ˚ from Lys9 NZ, although
in the latter case the geometry is not optimal for a
hydrogen bonding interaction.
AaIspE represents a template for inhibitor
development
M. tuberculosis is a particularly important human
pathogen. Approximately one-third of the world’s popu-
lation is infected with this organism, the causative agent
of tuberculosis, which was responsible for an estimated
1.6 million deaths in 2005 [23]. The need for novel che-
motherapeutics in the treatment of M. tuberculosis
infection is clearly demonstrated by its high infectivity
rate, the prolonged and extensive therapy requirements
and the increase in drug-resistant forms. New targets for
drug discovery research are urgently sought and the
non-mevalonate pathway provides potentially valuable
enzymes for such use [24,25]. Our studies of MtbIspE
have been hampered by poor solubility of the recombi-
nant enzyme and a failure to obtain crystals (data not
shown). To investigate whether the AaIspE structure
represents a model system to support inhibitor develop-
ment we compared the sequences (Fig. 7).
In the above sections we detailed 17 AaIspE residues
that interact with CDPME (directly or via water mole-
cules) or that contribute to the placement of functional
groups that bind the substrate. Of these, 11 residues are
strictly conserved. Five of the remainder are not signiﬁ-
cant because either main-chain groups interact by
hydrogen-bonding interactions (Ala129 ﬁ Ser,
OTBS
F
OTBS P
O
EtO
EtO
6
TFA
46%
OH
F
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O
EtO
EtO
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51%
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Scheme 2. Deprotection of compound 6 to produce compound 1.
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Fig. 10. Stereo-view of compound 1 bound in the active site. The map, purple mesh, has been calculated with coefﬁcients |Fo)Fc| and ac,
and contoured at 2.5r. Fo represents the observed structure factors, Fc represents the calculated structure factors and ac represents the cal-
culated phases for which ligand contributions were omitted. The model phases were generated from the ﬁnal reﬁned model. The ligand
atoms are shown as sticks and coloured C, cyan; O, red; F white; P, orange. Nearby is a sulfate (S yellow, O red). Water molecules are
shown as grey spheres. Potential hydrogen bonding interactions between 1 and the enzyme are shown as black dashed lines, and cytidine
C atoms are green. Residues important in binding 1 within the active site are labelled.
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bridges involved (Ser97 ﬁ Ala, Ser176 ﬁ Asn) or in
the case of the Ser⁄Asn change a direct interaction
might occur. The ﬁnal difference is Ser128 ﬁ Gly.
Ser128 OG interacts with the b-phosphate of CDPME.
Truncation of the side chain to glycine might allow a
water molecule to compensate for the loss of such an
interaction. Similar observations apply when comparing
the ATP-binding site. Of the 21 residues discussed
above, 10 are strictly conserved and they are mainly
those residues that make direct interactions with ATP.
Three changes (Ala91 ﬁ Gly, Leu93 ﬁ Met, Ser169
ﬁ Leu) involve residues that interact using main-chain
groups, or that use side chains to form the hydrophobic
purine binding pocket, e.g. Pro89 ﬁ Val. Two altera-
tions are of note. In AaIspE, the side-chain carbonyl
groups of Asn60 and Asn99 accept hydrogen bonds
from adenine N7 (Fig. 10B). In the sequence alignment
shown in Fig. 8, Asn60 and Asn99 correspond to Arg69
(a major alteration) and Asp109 (a conservative change)
of MtbIspE, respectively. There may be some difference
in MtbIspE such that Asn70 is actually placed to pro-
vide the same function as Asn60 of AaIspE.
Conclusions
We puriﬁed soluble recombinant AaIspE in high yield,
optimized the enzyme assay and kinetically character-
ized the enzyme, identiﬁed conditions that provide a reli-
able source of well-ordered crystals and determined a
series of structures with physiologically relevant ligands.
We designed and synthesized a fragment to mimic a
component of the substrate and provide a template for
inhibitor development. Surprisingly, when soaked into a
crystal the ligand adopts a position that overlays where
cofactor binds rather than substrate. The collection of
structures serves to inform on aspects of speciﬁcity and
reactivity of IspE. Sequence–structure comparisons indi-
cate that the active site and interactions with ligands are
highly conserved and that AaIspE represents a suitable
model for orthologues derived from human pathogens
including the important M. tuberculosis. We have shown
that the crystals are suitable for soaking in small ligands
and as such can support a fragment and structure-based
approach to underpin drug discovery targeting impor-
tant human diseases [26,27].
Experimental procedures
Cloning, expression and puriﬁcation
The gene-encoding sequence of AaIspE was identiﬁed in the
UniProt Database (entry O67060) and cloned from genomic
DNA by PCR using the following primers (NdeI and XhoI
restriction sites are underlined): forward: CATATGATAA
AGGTTCTATCACCCGCG, reverse: CTCGAGTTAGA
GTTCTAGCTCTACAAC. The gene was inserted into the
pCR blunt II TOPO vector (Invitrogen, Carlsbad, CA),
and then subcloned into the pET15b vector (Novagen,
Darmstadt, Germany) which was heat-shock transformed
into E. coli BL21 (DE3). Cells were cultured in Luria–Ber-
tani broth containing ampicillin (100 mgÆL
)1)a t3 7 C. Pro-
tein production was induced overnight at 30  C by addition
of 1 mm isopropyl-b-d-thiogalactoside. Following centrifu-
gation, cells were resuspended in 50 mm.
Tris⁄HCl pH 8.5, 250 mm NaCl and 3 mm b-mercapto-
ethanol and lysed using a French Press. Cell debris was
removed by centrifugation at 40 000 g and the supernatant
containing soluble protein was loaded onto a 5 mL Ni
2+
HisTrap column (GE Healthcare, Amersham, UK). AaIspE
was eluted with a linear imidazole gradient. The His6 tag
was removed by digestion with thrombin for 6 h at 4  C
and the sample dialysed against 50 mm Tris⁄HCl pH 8.5,
50 mm NaCl and 1 mm dithiothreitol. This was then
applied to a 5 mL HiTrapQ HP anion-exchange column
(GE Healthcare) and AaIspE eluted with a linear NaCl gra-
dient. After dialysis against 10 mm Tris⁄HCl pH 8.5,
20 mm NaCl and 1 mm dithiothreitol, the protein was con-
centrated with centrifugal force (VivaSpin20, molecular
mass cut-off 10 kDa; Vivascience, Littleton, MA). Concen-
tration was estimated using a theoretical extinction coefﬁ-
cient of 0.898 gÆL
)1 at 280 nm. The purity of the sample
was assessed by SDS⁄PAGE and MALDI-TOF MS.
To produce the SeMet derivative, the AaIspE⁄pET15b
plasmid was transformed into the E. coli methionine auxo-
troph B834Met
) (Stratagene, La Jolla, CA). Cultures were
grown in M9 minimal media supplemented with 4 mgÆL
)1
FeSO4.7H2O and 0.5 gÆL
)1 each of adenine, guanosine, thy-
mine and uracil. We added 40 mgÆL
)1 of all amino acids
with the exception of methionine, which was replaced by
100 mgÆL
)1 SeMet (Sigma Aldrich, Poole, UK). Protein
production and puriﬁcation were carried out as described
for the native protein. Full incorporation of SeMet was
conﬁrmed by MALDI-TOF MS.
Photometric assay for IspE enzyme activity
Assay mixtures contained 100 mm Tris⁄HCl, pH 8.5,
20 mm KCl, 10 mm MgCl2, 0.45 mm NADH, 2 mm ATP,
4m m phosphoenolpyruvate, 1 mm CDPME, 8 U pyruvate
kinase, 9 U lactate dehydrogenase and 3 lg AaIspE. The
assay mixtures were incubated at 37  C, and the reaction
monitored photometrically at 340 nm.
NMR assay for IspE enzyme activity
Assay mixtures contained 100 mm Tris⁄HCl, pH 8.5, 2 mm
MgCl2, 2.5 mm [1,3,4-
13C3]CDPME, 8 mm ATP, 23–100 lg
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total volume of 500 lL. The mixtures were incubated at
37  C for 30–60 min, terminated by the addition of EDTA
to a ﬁnal concentration of 25 mm and analysed by
13C NMR spectroscopy. This assay was used to determine
the temperature and metal-ion dependence.
Synthesis of conjugated the ﬂuoro-MEP analogue
All reactions were performed under an inert argon atmo-
sphere. Anhydrous tetrahydrofuran, dichloromethane
(DCM) and diethyl ether were obtained through a Pure
Solv 400-5MD solvent puriﬁcation system (Innovative
Technology, Inc., Cleveland, OH). All reagents purchased
from commercial sources were used without further puriﬁ-
cation, unless otherwise stated. Solvents were evaporated
under reduced pressure at 35  C using a Bu ¨ chi Rotavapor.
Proton magnetic resonance spectra (
1H NMR) were
recorded at 400 MHz using Bruker Avance400 or Bruker
DPX400 instruments. Chemical shifts, d are reported in
parts per million (p.p.m.), and are referenced to the residual
solvent peak. The order of citation in parentheses is (a)
number of equivalent nuclei (by integration), (b) multiplic-
ity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet),
(c) coupling constant, with J quoted in Hertz to the nearest
0.5 Hz and (d) assignment. Carbon magnetic resonance
spectra (
13C NMR) were recorded at 101 MHz using Bru-
ker Avance400 or Bruker DPX400 instruments. Chemical
shifts are quoted in p.p.m. and are referenced to the resid-
ual solvent peak. The assignment is quoted in parentheses.
Fluorine magnetic resonance spectra (
19F NMR) were
recorded at 376 MHz using a Bruker Avance400 instrument
referenced to CFCl3. Phosphorus magnetic resonance spec-
tra (
31P NMR) were recorded at 162 MHz using a Bruker
Avance400 instrument and are referenced to external phos-
phoric acid (d 0.00 p.p.m.). High-resolution mass spectra
were recorded on a JEOL JMS-700 spectrometer by electro-
spray ionization mass spectrometer operating at a resolu-
tion of 15 000 full widths at half height.
Infrared spectra were recorded as thin ﬁlms on NaCl
plates using a JASCO FT⁄IR 4100 instrument. Only signiﬁ-
cant absorptions (tmax) are reported in wavenumbers
(cm
)1) with the following abbreviations to describe absorp-
tion intensity: w, weak; m, medium; s, strong; and br,
broad. Optical rotations, [a]D values were recorded on a
Rudolph Research analytical Autopol V automatic polar-
imeter at 25  C, with the concentration and solvent
reported in brackets. Flash chromatography was carried
out using silica gel (Apollo Scientiﬁc Gel 60, 40–63 lm) as
the stationary phase. TLC was carried out using aluminium
sheets pre-coated with silica (Merck Silica Gel 60 F254).
Detection was under a UV light source (kmax 254 nm) or
through staining with anisaldehyde or potassium permanga-
nate solution, with subsequent heating. RF (retention
factor) values are quoted to ± 0.05. The speciﬁc details
and characterization of compounds are given below and in
Ghilagaber et al. [28].
1-[2,4-Bis-(tert-butyl-dimethyl-silanyloxy)-3-ﬂuoro-3-
methyl-butoxymethyl]-4-methoxy-benzene, 3
A )78  C solution of 2-ﬂuoro-4-(4-methoxy-benzyloxy)-2-
methyl-butane-1,3-diol 2 (0.27 g, 1.0 mm) in anhydrous
DCM (20 mL) was treated with trimethylsilyl triﬂuorome-
thanesulfonate (0.7 mL, 4.0 mm) and 2,6-lutidine (0.5 mL,
4.20 mm). The reaction mixture was stirred for 1.5 h at
)78  C, allowed to warm to room temperature, the aqueous
layer was extracted with DCM (3 · 20 mL), the combined
organic layers were dried over anhydrous magnesium sul-
fate and the solvent was removed under reduced pressure.
The crude product was puriﬁed on a silica gel column using
ethyl acetate⁄petroleum ether (15 : 85) to yield 510 mg
1-[2,4-bis-(tert-butyl-dimethyl-silanyloxy)-3-ﬂuoro-3-methyl-
butoxymethyl]-4-methoxy-benzene 4 (quantitative) as a
clear oil.
1H NMR (400 MHz, CDCl3): d = 7.26 (2H, d,
J = 8.6 Hz, ArH), 6.88 (2H, d, J = 8.7 Hz, ArH), 4.43
(2H, s, PhCH2), 4.08 (1H, td, J = 7.6, 2.2 Hz, CH), 3.81
(3H, s, OCH3), 3.70 (1H, d, J = 6.2 Hz, CHAHB), 3.65
(2H, m, CH2), 3.42 (1H, ddd, J = 9.6, 7.1, 2.0 Hz,
CHAHB), 1.22 (3H, d, JHF = 22.0 Hz, CFCH3), 0.90 (9H,
s, 3 · CH3), 0.88 (9H, s, 3 · CH3), 0.08 (6H, s, 2 · CH3),
0.06 (3H, s, CH3), 0.05 (3H, s, CH3).
13C NMR (100 MHz, CDCl3): d = 159.2 (ArC), 130.6
(ArC), 129.4 (2 · ArCH), 113.8 (2 · ArCH), 98.3 (d,
JCF = 172 Hz, CFCH3), 73.0, 72.8, 72.1, 65.9 (d,
JCF = 24.4 Hz), 55.4 (OCH3), 26.0 (6 · CH3), 18.4, 18.1,
17.5 (d, JCF = 22.1 Hz), )4.1 (CH3), )5.1 (CH3), )5.2
(CH3), )5.3 (CH3).
19F NMR (400 MHz, CDCl3): d = )159.20
RF [diethyl ether⁄petroleum ether (1 : 1)] 0.51
HRMS (ESI) calcd for C25H47FO4Si2 (M + Na
+):
486.2997. Found m⁄z 509.3300.
[a]D = )5.3 (c 1.15; DCM).
IR: tmax (ﬁlm) 2857 cm
)1 (s, O-CH3) and 1253 cm
)1 (s,
C-F).
2,4-Bis-(tert-butyl-dimethyl-silanyloxy)-3-ﬂuoro-3-
methyl-butan-1-ol, 4
A solution of 1-[2,4-bis-(tert-butyl-dimethyl-silanyloxy)-3-
ﬂuoro-3-methyl-butoxymethyl]-4-methoxy-benzene 3 (0.14 g,
0.29 mm) in anhydrous DCM (2.5 mL) was cooled to
)78  C. Thiophenol (0.04 mL, 0.36 mm) was added, imme-
diately followed by tin (IV) chloride (0.32 mL, 1.0 m in
DCM). The resulting mixture was then stirred for exactly
20 min and the reaction was quenched with saturated
sodium hydrogen carbonate (10 mL). The aqueous layer
was then extracted with DCM (3 · 20 mL), the combined
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fate and the solvent was removed under reduced pressure.
The crude residue was puriﬁed on a silica gel column using
ethyl acetate⁄petroleum ether (1%) to yield 90 mg 2,4-
bis-(tert-butyl-dimethyl-silanyloxy)-3-ﬂuoro-3-methyl-butan-
1-ol 4 (86%) as a clear oil.
1H NMR (400 MHz, CDCl3): d = 3.96 (1H, m, CH),
3.70 (4H, m, 2 · CH2), 2.06 (1H, td, J = 6.3, 1.7 Hz, OH),
1.28 (3H, d, JHF = 22.4 Hz, CFCH3), 0.91 (9H, s,
3 · CH3), 0.90 (9H, s, 3 · CH3), 0.07 (6H, s, 2 · CH3),
0.11 (3H, s, CH3), 0.12 (3H, s, CH3).
13C NMR (100 MHz, CDCl3): d = 95.9 (CFCH3, JCF =
172 Hz), 74.0 (d, JCF = 26.2 Hz), 65.5 (d, JCF = 27.1 Hz),
63.3 (d, JCF = 5.7 Hz), 26.0 (6 · CH3), 18.5, 18.3, 17.9,
)5.3 (CH3), )5.2 (CH3), )4.8 (CH3), )4.4 (CH3).
19F NMR (376 MHz, CDCl3): d = )157.8
RF [ethyl acetate⁄petroleum ether (2%)] 0.14
[a]D = )2.6 (c 1.16, CH2Cl2)
IR: tmax (ﬁlm) 1255 cm
)1 (s, C-F)
(E)-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-4-ﬂuoro-4-
methyl-pent-1-enyl]-phosphonic acid diethyl ester, 6
Dimethyl sulfoxide (90 lL, 1.30 mm) was added to a
)78  C solution of oxalyl chloride (60 lL, 0.65 mm)i n
anhydrous DCM (5 mL) and the resulting solution was stir-
red for 15 min. A solution of 2,4-bis-(tert-butyl-dimethyl-
silanyloxy)-3-ﬂuoro-3-methyl-butan-1-ol 4 (0.12 g, 0.33 mm)
in anhydrous DCM (5 mL) was added drop wise and the
reaction mixture was stirred for a further 30 min at )78  C.
Triethylamine (0.30 mL, 2.15 mL) was then added and the
reaction was allowed to warm to room temperature and left
to stir for 1 h. A 2 : 1 solution of diethylether and satu-
rated aqueous sodium hydrogen carbonate (45 mL) was
added and the aqueous layer was extracted with diethyle-
ther (3 · 20 mL). The combined organic layers were dried
over anhydrous magnesium sulfate and the solvent removed
under reduced pressure. The crude residue (0.15 g) of
2,4-bis-(tert-butyl-dimethyl-silanyloxy)-3,3-dimethyl-butyral-
dehyde 5 was used straight away without further puriﬁca-
tion.
1H NMR (400 MHz, CDCl3): d = 9.56 (1H, dd,
J = 5.1, 1.3 Hz, C(O)H), 4.15 (1H, dd, J = 10.8, 1.3 Hz,
CH), 3.82 (1H, t, J=10.0 Hz, CHAHB), 3.49 (1H, dd,
J = 13.9, 10.0 Hz, CHAHB), 1.32 (3H, d, J = 22.9 Hz,
CFCH3), 0.90 (9H, s, 3 · CH3), 0.87 (9H, s, 3 · CH3), 0.05
(12H, m, 4 · CH3). RF [petroleum ether] 0.26
Tetraethyl methylenediphosphonate (0.16 mL, 0.64 mm)
in dry tetrahydrofuran (6 mL) was cooled to )78  C and
stirred for 5 min. nBuLi (0.19 mL, 2.5 m sol. in hexane)
was added to the phosphate solution and the mixture stir-
red for 30 min at )78  C. A solution of the crude butyral-
dehyde 5 (0.15 g, 0.41 mm) in anhydrous tetrahydrofuran
(7 mL) was added, and the resulting solution was stirred
for 1 h at )78  C and then a further 1.5 h at room temper-
ature. The reaction was quenched with 10% ammonium
chloride solution (20 mL) and the aqueous layer extracted
with ethyl acetate (3 · 20 mL). The combined organic lay-
ers were dried over anhydrous magnesium sulfate and the
solvent removed under reduced pressure. The product was
puriﬁed on a silica gel column using ethyl acetate⁄
petroleum ether (2%) to yield 160 mg of the desired [3,5-bis-
(tert-butyl-dimethyl-silanyloxy)-4-ﬂuoro-4-methyl-pent-1-enyl]-
phosphonic acid diethyl ester 6 (quantitative yield over
both steps) as a clear oil.
1H NMR (400 MHz, CDCl3): d = 6.80 (1H, dddd,
J = 17.2, 4.3, 2.0 Hz, JHP = 22.1 Hz, CH), 5.93 (1H, ddd,
J = 17.2, 1.5, JHP = 22.1 Hz, CH), 4.54 (1H, m, CH),
4.06 (5H, m, 2 · CH2 and CHAHB), 3.63 (1H, m, CHAHB),
1.28 (6H, t, J = 7.1 Hz, CFCH3), 1.13 (3H, d,
JHF = 21.8 Hz, CFCH3), 0.87 (9H, s, 3 · CH3), 0.86 (9H,
s, 3 · CH3), 0.05 (3H, s, CH3), 0.03 (3H, s, CH3), 0.02 (3H,
s, CH3), )0.01 (3H, s, CH3).
13C NMR (100 MHz, CDCl3): d = 151.0 (d, JCP =5
Hz), 119.8 (d, JCP = 186.5 Hz), 97.5 (d, JCF = 176.9 Hz),
72.5 (d, JCF = 21.2 Hz), 72.2 (d, JCF = 21.3 Hz), 65.6,
61.8 (appt. t, JCP = 4.9 Hz), 26.0 (3 · CH3), 25.9
(3 · CH3), 18.4, 18.1, 16.8 (d, JCF = 22.2 Hz), 16.5, 16.4,
)4.3 (CH3), )5.1 (CH3), )5.2 (CH3), )5.4 (CH3).
19F NMR (376MHz, CDCl3): d = )160.35
31P NMR (162MHz, CDCl3): d = 18.48
RF [ethyl acetate⁄petroleum ether (3 : 7)] 0.22
HRMS (CI
+) calcd for C22H49FO5PSi2 (M + H)
+:
499.2840. Found m⁄z 499.2839.
[a]D = )10.6 (c 1.12, CHCl3).
IR: tmax (ﬁlm) 1258 cm
)1 (s, P=O).
4-Fluoro-3,5-dihydroxy-4-methyl-pent-1-enyl)-
phosphonic acid diethyl ester, 7
A solution of [3,5-bis-(tert-butyl-dimethyl-silanyloxy)-4-ﬂu-
oro-4-methyl-pent-1-enyl]-phosphonic acid diethyl ester 6
(0.44 g, 0.88 mm) in anhydrous DCM (2 mL) was treated
with 90% triﬂuoroacetic acid (4.08 mL, 54.93 mm). The
resulting solution was stirred at room temperature for
30 min and the volatile solvents were then removed on a
rotary evaporator. The product was puriﬁed on a silica gel
column using DCM⁄methanol (9 : 1 v⁄v) to yield 110 mg
of the desired 4-ﬂuoro-3,5-dihydroxy-4-methyl-pent-1-enyl)-
phosphonic acid diethyl ester 7 (46%) as a clear oil.
1H NMR (400 MHz, CDCl3): d = 6.87 (1H, ddm,
J = 20.8, 17.2 Hz, CH), 6.14 (1H, ddm, J = 21.0, 17.3 Hz,
CH), 4.59 (2H, m, CH2 and 2 · OH), 4.07 (4H, m, 2 · CH2),
3.74 (2H, m, CH2), 1.32 (6H, td, J = 7.0 Hz, JHP = 0.9 Hz,
2 · CH3), 1.17 (3H, d, JHF = 22.2 Hz, CFCH3).
13C NMR (100 MHz, CDCl3): d = 150.8 (d, JCP = 3.9
Hz) 118.5 (d, JCP = 188 Hz), 97.0 (d, JCF = 173.8 Hz), 71.9
(d, JCF = 71.9 Hz), 71.6 (d, JCF = 71.6 Hz), 66.1 (d,
JCF = 23.0 Hz, CH2), 62.4 (appt. t, J = 5.9 Hz, -CH2CH3),
17.1 (d, JCF = 22.4 Hz, -CFCH3), 16.4 (d, JCP = 6.4 Hz,
2 · )CH2CH3).
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19F NMR (376 MHz, CDCl3): d = )160
RF [DCM⁄MeOH (9 : 1)] 0.37
HRMS (CI
+) calcd for C10H21O5FP (M + H)
+:
271.1111. Found m⁄z 271.1107.
[a]D = )40.1 (c 0.94, CHCl3)
IR: tmax (ﬁlm) 3403 cm
)1 (br, O-H)
(4-Fluoro-3,5-dihydroxy-4-methyl-pent-1-enyl)-
phosphonic acid, 1
A solution of 4-ﬂuoro-3,5-dihydroxy-4-methyl-pent-1-enyl)-
phosphonic acid diethyl ester 7 (0.14 g, 0.52 mm) in anhy-
drous DCM (2 mL) was treated with TMSBr (0.46 mL,
3.49 mm) and stirred for 20 h at room temperature. The
volatile solvents were removed under vacuum and the resul-
tant residue was treated with a 1 : 1 solution of etha-
nol⁄water (4 mL) for 30 min and the solvents were once
again removed under reduced pressure. This process was
repeated three times and the crude residue was puriﬁed on
a silica gel column using methanol⁄DCM (1 ﬁ 10%) to
yield 60 mg of the desired (4-ﬂuoro-3,5-dihydroxy-
4-methyl-pent-1-enyl)-phosphonic acid 1 (51%) as a white
solid.
1H NMR (400 MHz, MeOD): d = 6.80 (1H, ddm,
J = 20.9, 17.3 Hz, CH), 6.19 (1H, dd, J = 20.4, 17.8 Hz,
CH), 4.95 (4H, s, 4 · OH), 4.48 (1H, m, CH), 3.71 (2H, m,
CH2), 1.22 (3H, d, JHF = 22.1, CFCH3).
13C NMR (100 MHz, MeOD): d = 148.6, 122.1 (d, JCP =
185.4 Hz), 99.59 (d, J = 174.2 Hz), 72.4 (d, JCF = 72.5 Hz),
72.2 (d, JCF = 72.3 Hz), 66.2 (d, JCF = 22.7 Hz, CH2), 16.9
(d, JCF = 22.8 Hz, CH3).
31P NMR (162 MHz, MeOD): d = 16.2
19F NMR (376 MHz, MeOD): d = )164.3
RF [DCM⁄MeOH (9 : 1)] 0.05
HRMS (FAB
+) calcd for C6H13O5FP (M + H)
+:
215.0485. Found m⁄z 215.0488.
[a]D = )21.4  (c 0.46, CH3OH)
IR: tmax (ﬁlm) 3410cm
)1 (br, O–H)
Crystallization
AaIspE was crystallized by vapor diffusion in hanging
drops assembled from 2 lL reservoir and 2 lL protein
solution at a concentration of 10 mgÆmL
)1. A reservoir of
0.1 m Mes pH 6.5, 0.20 m NaCl and 1.50 m (NH4)2SO4 was
used for the native protein. Crystals of SeMet AaIspE grew
with a reservoir of 0.1 m Mes pH 6.5, 0.50 m NaBr and
1.55 m (NH4)2SO4. Triangular prisms (maximum dimension
0.4 mm) grew after a few days at 18  C. SeMet and native
AaIspE (complex I) were co-crystallized with 4 mm AMP-
PNP and 4 mm CDP. Crystals were also grown in the pres-
ence of 20 mm ADP, 20 mm CDPME2P and 10 mm MgCl2
(complex II). For soaking experiments to obtain com-
plex III, a stabilizing solution of 0.1 m Mes pH 6.5, 0.2 m
NaCl and 1.8 m (NH4)2SO4 was used and crystals soaked
overnight with compound 1 at a concentration of 25 mm.
Data collection and processing
Following cryo-protection for 30 s (1 : 1 mixture of reser-
voir with 100% 2-methyl-2,4-pentanediol) the crystals were
cooled in a stream of nitrogen gas at )170  C for data col-
lection. Anomalous dispersion measurements were carried
out on SeMet crystals using beam-line ID14-4 at the Euro-
pean Synchrotron Radiation Facility (Grenoble, France). A
ﬂuorescence scan around the Se K-edge identiﬁed the wave-
lengths for multiple-wavelength anomalous dispersion data
collection. Data were collected at a peak: k1 = 0.97947 A ˚ ,
an inﬂection point: k2 = 0.97958 A ˚ and a high-energy
remote point: k3 = 0.97625 A ˚ using a Q315 ADSC CCD
detector. The SeMet crystals are cubic, in space group P213
with a unit cell edge of 137.8 A ˚ and diffracted to 2.7 A ˚
resolution.
Data were collected on beam-line ID23-1 at the E.S.R.F.
on a Q315 ADSC CCD detector or in-house using a Riga-
ku 007 Micromax rotating-anode generator (Cu Ka,
k = 1.5418 A ˚ ) operating at 30 mA and 40 kV, coupled to
an R-AXIS IV
++ dual image plate system. Data were
processed and scaled with mosflm⁄scala [29,30] or
denzo⁄scalepack [31]. Statistics are shown in Tables 3
and 4.
Structure determination
The program solve [32] identiﬁed three of four selenium
positions using data to 3.0 A ˚ resolution and gave a ﬁgure-
of-merit of 0.34 and a Z-score of 13. After density modiﬁ-
cation with resolve [33], the ﬁgure-of-merit increased to
0.72 and a correlation coefﬁcient of 0.38 was obtained.
resolve built an initial model of 446 (of 658) residues. The
missing residues were included by interpretation of electron
density using coot [34]. The model was used to initiate
reﬁnement of the ligand complexes using ﬁrst molrep [35]
then refmac [36]. Calculation of Rfree used 5% of the data.
Electron density and difference density maps, all
rA-weighted [37,38] were inspected and the model improved
using coot. A subset of the data (5%) was set aside for cal-
culation of Rfree. Electron and difference density map
inspection, model manipulation together with addition of
ligands including water molecules was carried out using
coot interspersed with TLS (translation, libration, screw
analysis) and maximum-likelihood restrained reﬁnement
with refmac. Strict non-crystallographic symmetry
restraints were applied at ﬁrst then released towards the
end of each reﬁnement. The quality of the model was
assessed with procheck [39]. Figures were prepared with
chemdraw (Adept Scientiﬁc, Letchworth Garden City,
UK) pymol (http://pymol.sourceforge.net) [40] and aline
(C. S. Bond, personal communication).
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Analytical gel-ﬁltration chromatography used a Superose
10⁄300 analytical gel-ﬁltration column (GE Healthcare) pre-
equilibrated with buffer and calibrated with molecular mass
standards, blue dextran (> 2000 kDa), BSA (67 kDa), car-
bonic anhydrase (29.5 kDa) and cytochrome c (12.5 kDa;
GE Healthcare; data not shown). AaIspE eluted at a volume
of 94 mL corresponding to an approximate molecular mass
of 30.0 kDa. Samples for analytical ultracentrifugation were
prepared in the crystallization buffer (see above) at concen-
trations of 0.25, 0.5 and 1.0 mgÆmL
)1. Sedimentation velocity
experiments were performed using a Beckman Coulter
(Fullerton, CA, USA) XL-1 analytical ultracentrifuge (wave-
length 280 nm, rotor AN50-TI at 45 000 r.p.m. and 20  C).
Samples were centrifuged simultaneously and A280 measure-
ments taken at 5 min intervals for 16 h. The resultant data
were analysed using sedfit and sednterp [41,42]. Analytical
ultracentrifugation returned a sedimentation coefﬁcient of
2.61s, which corresponds to a mass of  29.8 kDa (data not
shown).
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